Alexander Engel
Overview
Explore the profile of Alexander Engel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
645
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morrell S, Roder D, Currow D, Engel A, Hovey E, Lewis C, et al.
Front Oncol
. 2024 Sep;
14:1338754.
PMID: 39234396
Introduction: Population cancer registries record primary cancer incidence, mortality and survival for whole populations, but not more timely outcomes such as cancer recurrence, secondary cancers or other complications that disrupt...
2.
Sarofim M, Engel A
Colorectal Dis
. 2024 Apr;
26(6):1307-1308.
PMID: 38654421
No abstract available.
3.
Sarofim M, Ashrafizadeh A, Gill A, de Silva K, Evans J, Clarke S, et al.
ANZ J Surg
. 2024 Mar;
94(7-8):1279-1285.
PMID: 38553882
Background: Australia's National Bowel Cancer Screening Program consists of an immunohistochemical faecal occult blood test, targeting adults aged 50-74. Existing literature supports the principle of early detection of colorectal cancer...
4.
Sarofim M, Slaar A, Dermout S, den Boer F, Engel A
Colorectal Dis
. 2024 Jan;
26(3):508-514.
PMID: 38229253
Aim: Obstetric anal sphincter injuries (OASIS) occur in approximately 3%-6% of vaginal deliveries and are the leading risk factor for late-onset faecal incontinence, which is an underdiagnosed pathology. The aim...
5.
Tse B, Bergamin S, Steffen P, Hruby G, Pavlakis N, Clarke S, et al.
Oncoimmunology
. 2023 Jul;
12(1):2238506.
PMID: 37485033
Approximately 20% of locally advanced rectal cancer (LARC) patients treated preoperatively with chemoradiotherapy (CRT) achieve pathologically confirmed complete regression. However, there are no clinically implemented biomarkers measurable in biopsies that...
6.
McKay M, Castaneda M, Catania S, Charles K, Shanahan E, Clarke S, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 Feb;
1217:123618.
PMID: 36731355
The gut microbiome produces a range of short chain fatty acids (SCFA) crucially linked with diet and nutrition, metabolism, gastrointestinal health and homeostasis. SCFA are primarily measured using gas or...
7.
Sang R, Deng F, Engel A, Goldys E, Deng W
Biomed Pharmacother
. 2022 Oct;
155:113837.
PMID: 36271586
In this study, we brought together X-ray induced photodynamic therapy (X-PDT) and chemo-drug (5-FU) for the treatment on colorectal cancer cells. This was achieved by developing a lipid-polymer hybrid nanoparticle...
8.
Steinberg J, Chan P, Hogden E, Tiernan G, Morrow A, Kang Y, et al.
Hered Cancer Clin Pract
. 2022 May;
20(1):18.
PMID: 35509103
Background: To inform effective genomic medicine strategies, it is important to examine current approaches and gaps in well-established applications. Lynch syndrome (LS) causes 3-5% of colorectal cancers (CRCs). While guidelines...
9.
Gugusheff J, White K, Fitzadam S, Creighton N, Engel A, Lee M, et al.
J Surg Oncol
. 2022 Apr;
126(2):322-329.
PMID: 35362557
Purpose: International clinical guidelines recommend long- or short-course neoadjuvant radiotherapy for locally advanced rectal cancer. This study aims to examine variation in the use of neoadjuvant radiotherapy for rectal cancer...
10.
Toh J, Collins G, Pathma-Nathan N, El-Khoury T, Engel A, Smith S, et al.
Langenbecks Arch Surg
. 2022 Mar;
407(4):1637-1646.
PMID: 35275247
Background: Whilst Enhanced Recovery after Surgery (ERAS) has been widely accepted in the international colorectal surgery community, there remains significant variations in ERAS programme implementations, compliance rates and best practice...